These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574 [TBL] [Abstract][Full Text] [Related]
7. The cytoskeletal protein RHAMM and ERK1/2 activity maintain the pluripotency of murine embryonic stem cells. Jiang J; Mohan P; Maxwell CA PLoS One; 2013; 8(9):e73548. PubMed ID: 24019927 [TBL] [Abstract][Full Text] [Related]
8. Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Maris JM; Morton CL; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Reynolds CP; Kang MH; Wu J; Smith MA; Houghton PJ Pediatr Blood Cancer; 2010 Jul; 55(1):26-34. PubMed ID: 20108338 [TBL] [Abstract][Full Text] [Related]
10. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Zhou N; Singh K; Mir MC; Parker Y; Lindner D; Dreicer R; Ecsedy JA; Zhang Z; Teh BT; Almasan A; Hansel DE Clin Cancer Res; 2013 Apr; 19(7):1717-28. PubMed ID: 23403633 [TBL] [Abstract][Full Text] [Related]
11. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma. Görgün G; Calabrese E; Hideshima T; Ecsedy J; Perrone G; Mani M; Ikeda H; Bianchi G; Hu Y; Cirstea D; Santo L; Tai YT; Nahar S; Zheng M; Bandi M; Carrasco RD; Raje N; Munshi N; Richardson P; Anderson KC Blood; 2010 Jun; 115(25):5202-13. PubMed ID: 20382844 [TBL] [Abstract][Full Text] [Related]
12. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR. Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N Lab Invest; 2011 Mar; 91(3):379-91. PubMed ID: 20956971 [TBL] [Abstract][Full Text] [Related]
13. Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors. Kolberg M; Bruun J; Murumägi A; Mpindi JP; Bergsland CH; Høland M; Eilertsen IA; Danielsen SA; Kallioniemi O; Lothe RA Mol Oncol; 2017 Sep; 11(9):1156-1171. PubMed ID: 28556483 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. Carol H; Boehm I; Reynolds CP; Kang MH; Maris JM; Morton CL; Gorlick R; Kolb EA; Keir ST; Wu J; Wozniak AE; Yang Y; Manfredi M; Ecsedy J; Wang J; Neale G; Houghton PJ; Smith MA; Lock RB Cancer Chemother Pharmacol; 2011 Nov; 68(5):1291-304. PubMed ID: 21448591 [TBL] [Abstract][Full Text] [Related]
15. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077 [TBL] [Abstract][Full Text] [Related]
16. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237. Sloane DA; Trikic MZ; Chu ML; Lamers MB; Mason CS; Mueller I; Savory WJ; Williams DH; Eyers PA ACS Chem Biol; 2010 Jun; 5(6):563-76. PubMed ID: 20426425 [TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β. Ohishi J; Aoki M; Nabeshima K; Suzumiya J; Takeuchi T; Ogose A; Hakozaki M; Yamashita Y; Iwasaki H BMC Cancer; 2013 May; 13():224. PubMed ID: 23642185 [TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2. Zeng K; Bastos RN; Barr FA; Gruneberg U J Cell Biol; 2010 Dec; 191(7):1315-32. PubMed ID: 21187329 [TBL] [Abstract][Full Text] [Related]